尿路感染的菌体疗法:进展和未来的挑战
Chase J Morgan1, Haley Atkins2, Alan J Wolfe3
1School of Biological Sciences, Division of Molecular Biology, University of California San Diego, La Jolla, CA, 92093, USA.
International urogynecology journal
|May 13, 2025
概括
菌体疗法为尿路感染 (UTI) 提供了抗生素的有希望的替代方案,原因是抗菌素耐药性增加. 对标准化方案,剂量和尿路微生物组的进一步研究对于优化临床环境中菌体治疗疗效至关重要.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 菌体研究 研究 菌体研究
背景情况:
- 尿路感染 (UTI) 由于抗菌素耐药性增加,对公共卫生构成重大挑战.
- 菌体治疗,使用菌体向细菌,正在成为潜在的替代或辅助治疗尿路感染.
- 目前针对尿路感染的菌体治疗的临床应用受知识差距和不一致的研究报告所限制.
研究的目的:
- 审查尿路感染的菌体治疗的现状.
- 确定关键的研究重点,以优化菌体治疗的临床疗效.
- 解决阻碍菌素疗法在尿路感染治疗中的广泛应用的挑战.
主要方法:
- 对目前关于尿路感染病菌体治疗的研究进行了全面的文献审查.
- 审查的重点是确定菌素敏感性测试,菌素表征和微生物学评估中的不一致性.
- 对现有研究进行分析,以确定需要进一步研究的领域.
主要成果:
- 未来研究的关键领域包括确定最佳的菌体剂量和施用途径.
- 了解菌体-宿主和菌体-患者相互作用以及尿道微生物组的作用是必不可少的.
- 需要标准化的数据收集和报告,以及强大的随机临床试验.
结论:
- 菌体治疗作为治疗尿路感染的抗生素替代品具有显著的前景,特别是在抗菌素耐药性增加的情况下.
- 标准化方案,优化剂量策略和更深入地了解尿道微生物群对于成功的菌体治疗至关重要.
- 严格的临床试验是必要的,以确定疗效,并指导菌体治疗的整合到标准的尿路感染治疗.
相关概念视频
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:25Urinary Tract Infection II: Pathophysiology
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:17Urinary Tract Infection IV: Nursing Management
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.